Company

Exagen

Rocket Ship Rating

Rocket Ship Rating: 90 out of 100

Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company.

Also known as Exagen Inc.

Medical devices & diagnostics

Status: Operatingas of 2026-09-19
Business model: B2B
Headquarters: Vista, California, United States
Customers: physicians
Legal name: Exagen Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

We aid patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions.

Funding snapshot

Total raised: $88.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $6.6M2019-01-02

Funding rounds

Round, 2019: $6.6M2019-01-02, SEC form D sold, 4 investors
Round, 2017: $3.7M2017-05-04, SEC form D sold, 4 investors
Round, 2017: $1.3M2017-04-06, SEC form D sold, 5 investors
Round, 2017: $1.5M2017-02-24, SEC form D sold, 4 investors
Round, 2017: $996K2017-01-27, SEC form D sold, 4 investors
Round, 2016: $996K2016-12-12, SEC form D sold, 4 investors
Round, 2016: $996K2016-11-07, SEC form D sold, 4 investors
Round, 2016: $996K2016-10-05, SEC form D sold, 4 investors
Round, 2016: $1M2016-08-26, SEC form D sold, 4 investors
Round, 2016: $2.1M2016-06-21, SEC form D sold, 6 investors
Round, 2016: $16.8M2016-01-19, SEC form D sold, 13 investors
Round, 2015: $3M2015-10-09, SEC form D sold, 4 investors
Round, 2015: $3M2015-07-02, SEC form D sold, 3 investors
Round, 2015: $1.8M2015-02-19, SEC form D sold, 8 investors
Round, 2014: $4M2014-07-10, SEC form D sold, 12 investors
More rounds: 9 earlier rounds recorded

Products

Other: AVISE